Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

July 1,

2023

December 31,

2022

Assets

Current assets:

   Cash and cash equivalents

$   234,813

$   499,915

   Short-term investments

271,063

692,024

   Accounts receivable, net

98,256

71,437

   Inventories

145,523

100,417

   Prepaid expenses and other current assets

71,322

97,570

Total current assets

820,977

1,461,363

Property and equipment, net

152,358

152,016

Goodwill

376,389

376,389

Other intangible assets, net

72,003

84,907

Other assets, net

97,072

94,753

Total assets

$1,518,799

$2,169,428

Liabilities and Stockholders' Equity

Current liabilities:

   Accounts payable

$     55,102

$     89,860

   Revolving line of credit

80,000

--

   Deferred revenue and returns liability

11,105

6,780

   Other current liabilities

72,339

89,136

Total current liabilities

218,546

185,776

Convertible debt, net

--

529,573

Other non-current liabilities

41,356

49,071

Total liabilities

259,902

764,420

Commitments and contingencies

Stockholders' equity:

   Preferred stock – $0.0001 par value; 10,000 shares authorized; no

      shares issued

--

--

   Common stock – $0.0001 par value; 250,000 shares authorized;  

      31,861 and 31,994 shares issued and outstanding at

      July 1, 2023 and December 31, 2022, respectively

3

3

   Retained earnings

1,262,984

1,415,693

   Accumulated other comprehensive loss

(4,090)

(10,688)

Total stockholders' equity

1,258,897

1,405,008

Total liabilities and stockholders' equity

$1,518,799

$2,169,428